Pharma News News & Articles

1 FDA warns of pediatric accidental exposure to fentanyl patch Full Text Drug Topics, May 18, 2012

2 Covidien introduces halo90 ultra ablation catheter for treatment of barretts esophagus Covidien, May 18, 2012

3 Human genome sciences board of directors unanimously determines glaxosmithkline unsolicited tender offer is inadequate and not in the best interests of stockholders Full Text Human Genome Sciences, May 18, 2012

4 Medtronic in.pact drug-eluting balloon studies show significant benefit of novel medical device in treating narrowed arteries Full Text Medtronic, May 18, 2012

5 Nucynta er (tapentadol) extended-release tablets show positive phase-3 results in providing pain management for patients with diabetic peripheral neuropathy (dpn) Ortho-McNeil, May 18, 2012

6 Medtronic receives notification that U.S. department of justice and U.S. attorney's office have closed their investigation of activities relating to infuse bone graft Full Text Medtronic, May 18, 2012

7 Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial Clinical Pharmacology & Therapeutics, May 18, 2012

8 Lower rates of intracranial hemorrhage seen with Pradaxa Full Text Drug Topics, May 18, 2012

9 Human genome sciences announces adoption of short-term stockholder rights plan Full Text Human Genome Sciences, May 18, 2012

10 Novartis nva237 phase iii data showed rapid, sustained improvement in lung function and symptom relief over one year in copd patients Full Text Novartis, May 18, 2012

11 GSK statement on tender offer to acquire Human Genome Sciences Full Text GlaxoSmithKline, May 18, 2012

12 The personal touch in digital promotion PharmExec, May 18, 2012

13 Abbott launches pediasure sidekicks clear for picky eaters Abbott, May 17, 2012

14 GlaxoSmithKline completes transaction to increase its ownership in Theravance Full Text GlaxoSmithKline, May 17, 2012

15 Over 25 years of successful collaboration between adidas and Bayer MaterialScience-A tango for the ball season Full Text BayNews International, May 17, 2012

16 Medtronic in.pact drug-eluting balloon studies show significant benefit of novel medical device in treating narrowed arteries Full Text Medtronic, May 17, 2012

17 Medtronic Foundation and Project HOPE to Rebuild Town Hospital in Northeastern Japan Devastated by March 2011 Tsunami Medtronic, May 17, 2012

18 Aveo and astellas announce positive findings from tivo-1 superiority study of tivozanib in first line advanced rcc Full Text Astellas, May 17, 2012

19 Ariad Announces Updated Findings from Pivotal Pace Trial of Ponatinib to Be Presented at Annual Meeting of American Society of Clinical Oncology Full Text ARIAD Pharmaceuticals, May 17, 2012

20 Inside pic/s: top gmp deficiencies Full Text Pharmaceutical Technology, May 17, 2012

1 Abbott to present positive phase 2 results from multiple interferon-free studies of combination regimens for the treatment of hepatitis c Abbott, April 5, 2012

2 AstraZeneca launches DUTOPROL (metoprolol succinate extended release/hydrochlorothiazide) tablets for high blood pressure in U.S. AstraZeneca, April 13, 2012    Free full text

3 Bayer HealthCare aims to improve diabetes management across borders BayNews International, April 13, 2012    Free full text

4 Ruxolitinib (Jakafi): A twice-daily oral kinase inhibitor indicated for the treatment of myelofibrosis Formulary , April 4, 2012    Free full text

5 Watson's generic vancocin HCL capsules receive FDA approval Watson Pharmaceuticals, April 11, 2012    Free full text

6 Label change of liraglutide demonstrates superiority compared to sitagliptin Drug Topics, April 17, 2012    Free full text

7 Fake avastin circulating in U.S. U.S. Pharmacist, April 9, 2012    Free full text

8 FDA approves once-monthly treatment for anemic adults on dialysis Drug Topics, April 5, 2012    Free full text

9 Seven years-over seven million patients served PhRMA, April 6, 2012    Free full text

10 Ucb and amgen initiate sclerostin antibody phase 3 program in patients with postmenopausal osteoporosis Amgen, April 6, 2012    Free full text

11 Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis Clinical Cancer Research, April 3, 2012

12 Biomarin to host first quarter 2012 financial results conference call and webcast on thursday, april at 5:00 p.m. et BioMarin, April 6, 2012    Free full text

13 Off-label use of drugs and medical devices: a review of policy implications Clinical Pharmacology & Therapeutics, April 13, 2012

14 FDA advisory committee recommends approval of mirabegron- investigational overactive bladder treatment from astellas Astellas, April 6, 2012    Free full text

15 Blood-pressure drug might curb PTSD-related nightmares Drug Topics, April 13, 2012    Free full text

16 Update on the treatment and prevention of community-acquired pneumonia in children U.S. Pharmacist, April 6, 2012    Free full text

17 Abbott receives approval for next-generation xience prime drug eluting stent in japan Abbott, April 10, 2012

18 Selumetinib controlled recurrent low-grade serous ovarian cancer Array BioPharma, April 3, 2012    Free full text

19 FDA approves Votrient for treatment of patients with certain types of advanced soft tissue sarcoma GlaxoSmithKline, April 27, 2012    Free full text

20 Brilinta (ticagrelor) added to american college of chest physicians recommendations on antithrombotic therapy and prevention of thrombosis AstraZeneca, February 22, 2012    Free full text